Akorn, Inc.

AKRX
NASDAQ
Company profile


Market capMicro (215.71M)
Company CEODouglas S. Boothe

Akorn, Inc.

AKRX
NASDAQ
Company profile


Market capMicro (215.71M)
Company CEODouglas S. Boothe
$1.71Price snapshot
-Annual dividend
N/ADividend yield
UnknownDividend growth (3y)
N/ATraling P/E
-Forward P/E
-Payout ratio
-EPS

AKRX DIVIDEND PAYOUT HISTORY

Loading...

Akorn, Inc. engages in the development, manufacture, and marketing of generic and prescription pharmaceuticals, and animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health business segments. The Prescription Pharmaceuticals segment manufactures and markets generic and branded prescription pharmaceuticals including ophthalmic, injectable, oral liquids, topical, inhalants, and nasal sprays.

The Consumer Health segment offers branded and private-label animal health; and over-the-counter products.

PRICE HISTORY Akorn, Inc.

Loading price stock history...

Akorn, Inc. latest news

Loading latest news...